methyl 2-hydroxy-4-(2-methoxyphenyl)-4-oxobut-2-enoate, 97%, 500mg

((2,6-dichlorophenyl)sulfonyl)valine, 95.0%, 250mg

4-anisaldeide, minimo 97,5%, 25 g, confezione in vetro

(S)-2-(((TERT-BUTYLDIMETHYLSILYL)OXY)METHYL)PYRROLIDINE, 97.0%, 1g

(R)-tert-Butyl (piperidin-2-ylmethyl)carbamate, 95.0%, 1g

Methyl 2-hydroxy-3-methylbutanoate, 97%, 1g

N-Butylbenzimidazole, 98%, 250mg

5-Methyl-1,3-cyclohexanedione>98.0%(GC)(T)1g

(R)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-(3-bromophenyl)propanoic acid, 98%, 5g

TERT-BUTYL 2-IODO-4-NITROPHENYLCARBAMATE, 95.0%, 250mg

Agarosio a basso punto di fusione, 100 g

Vetrini coprioggetto spessore 1.5H, 22 x 22 mm, 2000 pezzi 2000 pezzi

(S)-(2,3-Dihydrobenzo[b][1,4]dioxin-2-yl)methanamine, 95.0%, 100mg